An Evaluation of the ADR Monitoring Center's Impact on Pharmacovigilance: A Cross-Sectional Study of Outpatients at a Multi-Super Specialty Hospital in Nellore

Abstract

Objectives: The purpose of this study is to assess the level of staff and patient understanding of adverse 
drug reaction (ADR) and pharmacovigilance systems at a super specialty hospital. In addition, we want 
to raise patients' awareness of the ADR reporting system. Research Tools and Procedures: At a hospital 
with several different specialties, researchers performed a cross-sectional study. A random sample of 
outpatients seeking medical attention at KIMS multi-specialty hospital were surveyed, and their 
demographic information was recorded. Created for the study: a questionnaire to gauge level of 
understanding and sentiment about ADR. Both Telugu and English versions of the demographic data 
form and questionnaire are provided. The people who took part in the research were given patient 
information booklets. We educated patients on how to use the ADR PvPI app to report adverse drug 
reactions yourself. Descriptional analysis was used to examine the data. The results show that the 
patients who visited the tertiary care hospital had a better understanding of ADR than the individuals 
who did not. There were fifty patients included in the trial. There was a significant lack of knowledge of 
pharmacovigilance among the participants (56%). The internet and social media had a significant role in 
raising awareness about this topic. Fifteen people (or 30% of the total) have reported adverse drug 
reactions (ADRs) after taking medicine, although only ten of those people really told their doctors about 
it. To a large extent, they do not see ADR reporting as critical. Additional factors contributing to 
underreporting of adverse drug reactions were transportation challenges and hospital rush. The 
pharmacovigilance center was unknown to all of the participants. They would rather inform their doctor 
about adverse drug reactions (ADRs). It is estimated that almost all patients (96%) were unaware of 
the ADR PvPI app. Results: Everyone who took part in the study learned how to use the ADR PvPI app 
to record their own adverse drug reactions. All participants were given a patient education booklet that 
explained adverse drug reactions (ADRs), where they might find the institution's pharmacovigilance 
center, and what to do if an ADR occurs